Streetbeat News

Price Targets

TSX:ATD

RBC Capital analyst Irene Nattel maintains an Outperform rating on Alimentation Couche-Tard and raises the price target from C$87 to C$94.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:01 pm

HMY

JP Morgan analyst Luke Nelson has maintained a Neutral rating on Harmony Gold Mining Co (NYSE:HMY) and lowered the price target from $3.8 to $3.4.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:00 pm

FE

JP Morgan analyst Jeremy Tonet has maintained a Neutral rating on FirstEnergy (NYSE:FE) and lowered the price target from $42 to $39.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:55 pm

FQVLF

JP Morgan analyst Patrick Jones has maintained a Neutral rating on First Quantum Minerals (OTC:FQVLF) and lowered the price target from C$27 to C$26.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:53 pm

CLDX

Cantor Fitzgerald analyst Kristen Kluska has reiterated an Overweight rating on Celldex Therapeutics (NASDAQ:CLDX) and maintained a $54 price target.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:52 pm

ENR

JP Morgan analyst Andrea Teixeira maintains a Neutral rating on Energizer Holdings (ENR) and lowers the price target from $35 to $33.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:50 pm

JSPR

Cantor Fitzgerald analyst Pete Stavropoulos has reiterated an Overweight rating on Jasper Therapeutics (NASDAQ:JSPR) and maintained a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:50 pm

ELF

JP Morgan analyst Andrea Teixeira maintains an Overweight rating on e.l.f. Beauty (NYSE:ELF) but has lowered the price target from $150 to $139.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:48 pm

COTY

JP Morgan analyst Andrea Teixeira maintains a Neutral rating on Coty (NYSE:COTY) and lowers the price target from $13 to $12.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:47 pm

CL

JP Morgan analyst Andrea Teixeira has maintained an Overweight rating on Colgate-Palmolive (NYSE:CL) but lowered the price target from $85 to $81.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 3:45 pm